WASGAU Produktions & Handels AG
MSHGN.F operates in the Food Retail & Distribution industry, generating revenue primarily through the sale of food and drug products to consumers.
Business. MSHGN.F is a food and drug retailing company listed on the Frankfurt Stock Exchange. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on the Food Retail & Distribution industry. It generates revenue through the sale of products, with key performance indicators including same-store sales growth, traffic, and average ticket size. Specific details regarding operating segments, headquarters location, and geographic mix are not available in the provided data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
MSHGN.F is a food and drug retailing company listed on the Frankfurt Stock Exchange. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on the Food Retail & Distribution industry. It generates revenue through the sale of products, with key performance indicators including same-store sales growth, traffic, and average ticket size. Specific details regarding operating segments, headquarters location, and geographic mix are not available in the provided data.
MSHGN.F has a debt-to-equity ratio of 2.0, indicating a capital structure that is significantly leveraged. The company's liquidity position is characterized as medium risk, with a current ratio of 1.31, suggesting it has sufficient short-term assets to cover its short-term liabilities, but not with a large margin of safety. The company's free cash flow of 14.91 million EUR indicates it is generating positive cash from operations after capital expenditures, but the amount is relatively modest compared to its total assets of 398.6 million EUR.
Profitability metrics for MSHGN.F show a return on equity (ROE) of 2.09% and a return on assets (ROA) of 0.59%, both of which are below the typical thresholds for strong performance in the retail sector. The company's operating income of 11.14 million EUR and net income of 2.35 million EUR suggest that while it is profitable, its margins are thin, and it is not generating substantial returns relative to its asset base.
The company's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification in the provided data. This lack of geographic segmentation implies that the company's performance is closely tied to the local market, which could expose it to regional economic fluctuations and regulatory changes.
Looking at the growth trajectory, MSHGN.F reported a revenue of 654.5 million EUR in the latest period, with an operating cash flow of 36.4 million EUR. While the company is generating positive cash flow, the absence of forward-looking guidance or analyst estimates for the next fiscal year makes it difficult to assess the sustainability of this growth.
The risk assessment for MSHGN.F highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could limit its ability to fund operations or invest in growth opportunities without external financing. However, the low dilution risk suggests that the company is not currently issuing a significant number of new shares, which is a positive sign for existing shareholders.
Recent events and filings for MSHGN.F are not detailed in the provided data, but the company's financial performance and risk profile suggest that it is operating in a competitive and capital-intensive industry. The company's ability to maintain or improve its profitability and liquidity will be critical to its long-term success.
- MSHGN.F has a high debt-to-equity ratio of 2.0, indicating a leveraged capital structure.
- The company's ROE of 2.09% and ROA of 0.59% are below typical performance benchmarks in the retail sector.
- MSHGN.F's revenue is concentrated in the Food & Drug Retailing segment, with no geographic diversification disclosed.
- The company's liquidity position is characterized as medium risk, with a current ratio of 1.31.
- MSHGN.F has a low dilution risk, suggesting it is not currently issuing a significant number of new shares.
- The company's net cash position is negative after accounting for total debt, which could limit its ability to fund operations or invest in growth opportunities without external financing.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- MSHGN.F Market data — financials · 2026-05-28
- WASGAU Produktions & Handels AG Market data — analyst estimates · 2026-05-28
Ownership & reference
Leadership
- Christian MielschChairman of the Supervisory Board
- Thomas BingsMember of the Management Board